Douglas Nemec

Douglas Nemec is head of Skadden’s Intellectual Property Litigation Group, concentrating his practice on litigating complex cases involving intellectual property and technology.

In the diverse range of matters Mr. Nemec has led in state and federal courts from coast to coast, he has obtained positive results for clients in matters ranging from patent infringement to trade secrets to high-stakes licensing disputes. The technologies involved have been equally wide-ranging. With a background in bioengineering, Mr. Nemec has a particular fondness for life sciences matters, but has equal aptitude helping judges and juries to understand technological matters involving computers, electronics, industrial chemicals and mechanical structures.

Working alongside Skadden’s corporate practice, Mr. Nemec has significant experience beyond litigation, including advising on mergers and acquisitions, licensing, and general IP counseling. As a registered patent attorney, he also represents clients in matters before the U.S. Patent and Trademark Office, which has become an important complement to the firm’s IP litigation practice. Additionally, in life sciences matters, Mr. Nemec has advised on defense of patent infringement claims, enforcement of patent and other IP rights, and inter partes reviews related to the treatment of a variety of ailments and diseases.

Board of Directors, Volunteer Lawyers for the Arts

"Intellectual Property: Appointments, AI Policies, Patent Bills and FTC Action Could Shake Up the Field" (January 31, 2025, Skadden Publication / Executive Briefing: Latest Updates on the Trump Administration)

"The FTC Challenges Companies’ Allegedly Improper Orange Book Patent Listings" (Skadden Insights – June 2024)

"New Developments Help Clarify Intersection of Patent Law and Artificial Intelligence" (March 25, 2024, Skadden Publication / AI Insights)

Mr. Nemec has been repeatedly recognized by Chambers USA and The Best Lawyers in America, as well as by Lawdragon as one of its 500 Leading Litigators in America and 500 Leading Global IP Lawyers. In addition, he has been noted as a leader in IP by LMG Life Sciences and Intellectual Asset Management’s IAM Patent 1000, as well as a BTI Client Service All-Star by BTI Consulting Group. He was also recognized as a finalist for Litigator of the Year — New York in 2024 by Managing IP, which has repeatedly named him an IP Star and Patent Star.

University of Minnesota Law School

J.D.

1996

University of Pennsylvania

B.S.E., Bioengineering

1993